Analysis of serious adverse drug reactions in VEGF-A inhibitors (2015)
Source: Brazilian Journal of Pharmaceutical Sciences. Conference titles: Pharmaceutical Science and Technology Meeting of the Faculty of Pharmaceutical Sciences, University of São Paulo. Unidade: FCF
Subjects: DEGENERAÇÃO MACULAR, FÁRMACOS
ABNT
CAVALCANTE, João Augusto Bianchini e RIBEIRO, Adalton Guimarães e KANO, Eunice Kazue. Analysis of serious adverse drug reactions in VEGF-A inhibitors. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 03 maio 2024. , 2015APA
Cavalcante, J. A. B., Ribeiro, A. G., & Kano, E. K. (2015). Analysis of serious adverse drug reactions in VEGF-A inhibitors. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.NLM
Cavalcante JAB, Ribeiro AG, Kano EK. Analysis of serious adverse drug reactions in VEGF-A inhibitors. Brazilian Journal of Pharmaceutical Sciences. 2015 ; 51 41 res. FCF078.[citado 2024 maio 03 ]Vancouver
Cavalcante JAB, Ribeiro AG, Kano EK. Analysis of serious adverse drug reactions in VEGF-A inhibitors. Brazilian Journal of Pharmaceutical Sciences. 2015 ; 51 41 res. FCF078.[citado 2024 maio 03 ]